Infectious morbidity in gynecologic oncologic surgery. A clinical and economic evaluation.
In the Department of Obstetrics and Gynecology, Faculty of Medicine, Varese, between March 1991 and February 1992, 70 consecutive patients undergoing elective oncologic surgery were evaluated for rationalizing the use of antibiotics in order to reduce the cost of infectious complications. We divided our patients into two groups: a high infection risk group and a low infection risk group. Our findings show that: the HIR group shows a higher antibiotic cost than LIR one; our selection criteria for HIR patients are probably correct; in the LIR group 46.6% of patients were not submitted to any antibiotic therapy.
Franchi
M
M
Obstetric and Gynecologic Department, Ospedale di Circolo, Varese, Italy.
Salvatore
S
S
Zanaboni
F
F
Tusei
A
A
Scorbati
E
E
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D005260:Female; D005500:Follow-Up Studies; D005833:Genital Neoplasms, Female / Q000601:surgery*; D006801:Humans; D017053:Infection Control / Q000191:economics*; D007239:Infections / Q000453:epidemiology* / Q000209:etiology; D009017:Morbidity; D011183:Postoperative Complications / Q000453:epidemiology* / Q000517:prevention & control; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000517:prevention & control; D014552:Urinary Tract Infections / Q000453:epidemiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents